Scale Up

Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Nov 01, 2017
BioPharm International
Platform technologies facilitate
development and accelerate commercialization of protein therapeutics.
May 01, 2017
BioPharm International
Can bioprocessing runs be consistently replicated in an inherently variable production environment?
Jan 04, 2017
By BioPharm International Editors
Prokarium in the UK and Probiomed in Mexico hope to demonstrate large-scale production of oral vaccines that will reduce cost compared to injections and improve availability.
Jan 01, 2017
BioPharm International
There is much work to do to achieve efficient, cost-effective production processes.
Oct 15, 2016
BioPharm International
Classical production in cell-based systems such as mammalian and bacterial cells requires cell line development and lengthy process development to support scale-up. With plant technology, generic plant bioreactors can be grown rapidly and then transfected with a transient vector based system to produce proteins in days. Large-scale commercial facilities are now available in the US, enabling clinical or commercial production of significant quantities of therapeutic materials within a year.
Jul 14, 2016
This new method uses inter-alpha inhibitors to promote attachment and long-term growth in stem cells.
Jun 01, 2016
BioPharm International
Scale-up of complex, innovative products requires commercialization models that are sustainable.
May 31, 2016
BioPharm sat down with an intellectual property lawyer to examine how companies are protected when they engage in activities where sharing of trade secrets must occur.
Apr 01, 2016
BioPharm International
A modular cell-culture platform demonstrates accelerated process development.
lorem ipsum